Literature DB >> 15824318

Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability.

Alexandra Beilina1, Marcel Van Der Brug, Rili Ahmad, Sashi Kesavapany, David W Miller, Gregory A Petsko, Mark R Cookson.   

Abstract

Several mutations in PTEN-induced putative kinase 1 (PINK1) gene have been reported to be associated with recessive parkinsonism. The encoded protein is predicted to be a Ser/Thr protein kinase targeted to mitochondria. In this study, we have investigated the effects of mutations on PINK1 kinase activity in vitro and on expression levels and localization in mammalian cells. We chose to examine two point mutations: G309D, which was originally reported to be stable and properly localized in cells and L347P, which is of interest because it is present at an appreciable carrier frequency in the Philippines. We were able to confirm kinase activity and produce artificial "kinase-dead" mutants that are stable but lack activity. The L347P mutation grossly destabilizes PINK1 and drastically reduces kinase activity, whereas G309D has much more modest effects on these parameters in vitro. This finding is in line with predictions based on homology modeling. We also examined the localization of PINK1 in transfected mammalian cells by using constructs that were tagged with myc or GFP at either end of the protein. These results show that PINK1 is processed at the N terminus in a manner consistent with mitochondrial import, but the mature protein also exists in the cytosol. The physiological relevance of this observation is not yet clear, but it implies that a portion of PINK1 may be exported after processing in the mitochondria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15824318      PMCID: PMC556294          DOI: 10.1073/pnas.0500617102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Protein import into mitochondria.

Authors:  W Neupert
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

2.  Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease.

Authors:  Ekaterina Rogaeva; Janel Johnson; Anthony E Lang; Cindy Gulick; Katrina Gwinn-Hardy; Toshitaka Kawarai; Christine Sato; Angharad Morgan; John Werner; Robert Nussbaum; Agnes Petit; Michael S Okun; Aideen McInerney; Ronald Mandel; Justus L Groen; Hubert H Fernandez; Ron Postuma; Kelly D Foote; Shabnam Salehi-Rad; Yan Liang; Sharon Reimsnider; Anurag Tandon; John Hardy; Peter St George-Hyslop; Andrew B Singleton
Journal:  Arch Neurol       Date:  2004-12

3.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

4.  PINK1 (PARK6) associated Parkinson disease in Ireland.

Authors:  D G Healy; P M Abou-Sleiman; J M Gibson; O A Ross; S Jain; S Gandhi; D Gosal; M M K Muqit; N W Wood; T Lynch
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

Review 5.  Mitochondrial injury: a hot spot for parkinsonism and Parkinson's disease?

Authors:  Benoit I Giasson
Journal:  Sci Aging Knowledge Environ       Date:  2004-12-01

6.  L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system.

Authors:  David W Miller; Rili Ahmad; Stephen Hague; Melisa J Baptista; Rosa Canet-Aviles; Chris McLendon; Donald M Carter; Peng-Peng Zhu; Julia Stadler; Jayanth Chandran; Gary R Klinefelter; Craig Blackstone; Mark R Cookson
Journal:  J Biol Chem       Date:  2003-07-08       Impact factor: 5.157

7.  Novel PINK1 mutations in early-onset parkinsonism.

Authors:  Yasuko Hatano; Yuanzhe Li; Kenichi Sato; Shuichi Asakawa; Yasuhiro Yamamura; Hiroyuki Tomiyama; Hiroyo Yoshino; Masato Asahina; Susumu Kobayashi; Sharon Hassin-Baer; Chin-Song Lu; Arlene R Ng; Raymond L Rosales; Nobuyoshi Shimizu; Tatsushi Toda; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

8.  Import into mitochondria, folding and retrograde movement of fumarase in yeast.

Authors:  C Knox; E Sass; W Neupert; O Pines
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

9.  Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7).

Authors:  Robert Hering; Karsten M Strauss; Xiao Tao; Andreas Bauer; Dirk Woitalla; Eva-Maria Mietz; Slobodanka Petrovic; Peter Bauer; Wilhelm Schaible; Thomas Müller; Ludger Schöls; Christine Klein; Daniela Berg; Philipp T Meyer; Jörg B Schulz; Bernd Wollnik; Liang Tong; Rejko Krüger; Olaf Riess
Journal:  Hum Mutat       Date:  2004-10       Impact factor: 4.878

Review 10.  Mitochondria and dopamine: new insights into recessive parkinsonism.

Authors:  Jie Shen; Mark R Cookson
Journal:  Neuron       Date:  2004-08-05       Impact factor: 17.173

View more
  152 in total

1.  Pink1 kinase and its membrane potential (Deltaψ)-dependent cleavage product both localize to outer mitochondrial membrane by unique targeting mode.

Authors:  Dorothea Becker; Judith Richter; Maja A Tocilescu; Serge Przedborski; Wolfgang Voos
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

2.  PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.

Authors:  Ravi S Akundi; Lianteng Zhi; Hansruedi Büeler
Journal:  Neurobiol Dis       Date:  2011-09-16       Impact factor: 5.996

3.  PINK1 stimulates interleukin-1β-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1.

Authors:  Hyun Jung Lee; Sung Hee Jang; Hyeyoung Kim; Joo Heon Yoon; Kwang Chul Chung
Journal:  Cell Mol Life Sci       Date:  2012-05-29       Impact factor: 9.261

4.  Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin.

Authors:  Michael Lazarou; Seok Min Jin; Lesley A Kane; Richard J Youle
Journal:  Dev Cell       Date:  2012-01-25       Impact factor: 12.270

5.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

Authors:  Yufeng Yang; Stephan Gehrke; Yuzuru Imai; Zhinong Huang; Yingshi Ouyang; Ji-Wu Wang; Lichuan Yang; M Flint Beal; Hannes Vogel; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

Review 6.  Programmed cell death and new discoveries in the genetics of parkinsonism.

Authors:  Robert E Burke
Journal:  J Neurochem       Date:  2007-12-10       Impact factor: 5.372

7.  Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia.

Authors:  William Lin; Natasha L Wadlington; Linan Chen; Xiaoxi Zhuang; James R Brorson; Un Jung Kang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

8.  Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Authors:  Nicole Exner; Bettina Treske; Dominik Paquet; Kira Holmström; Carola Schiesling; Suzana Gispert; Iria Carballo-Carbajal; Daniela Berg; Hans-Hermann Hoepken; Thomas Gasser; Rejko Krüger; Konstanze F Winklhofer; Frank Vogel; Andreas S Reichert; Georg Auburger; Philipp J Kahle; Bettina Schmid; Christian Haass
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

9.  PINK1 rendered temperature sensitive by disease-associated and engineered mutations.

Authors:  Derek P Narendra; Chunxin Wang; Richard J Youle; John E Walker
Journal:  Hum Mol Genet       Date:  2013-03-03       Impact factor: 6.150

Review 10.  The PINK1/Parkin pathway: a mitochondrial quality control system?

Authors:  Alexander J Whitworth; Leo J Pallanck
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.